Old Web
English
Sign In
Acemap
>
authorDetail
>
Elizabeth Cruz
Elizabeth Cruz
Memorial Sloan Kettering Cancer Center
Medicine
Somatostatin
Neuroendocrine tumors
well differentiated
Pathology
3
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well differentiated neuroendocrine tumors (WDNETs).
2021
Journal of Clinical Oncology
Nitya Raj
Elizabeth Cruz
Joanne F. Chou
Marinela Capanu
Olivia Heffernan
Tiffany Le
Haley Hauser
Leonard B. Saltz
Diane Lauren Reidy
Show All
Source
Cite
Save
Citations (0)
Giving Voice to Patient Values Throughout Cancer: A Novel Nurse-Led Intervention
2019
Journal of Pain and Symptom Management
Andrew S. Epstein
Anjali V. Desai
Camila Bernal
Danielle R. Romano
Peter Justin Wan
Molly Okpako
Kelly Anderson
Kimberly Chow
Dana Kramer
Claudia Calderon
Virginia V. Klimek
Robin Rawlins-Duell
Diane Lauren Reidy
Jessica Goldberg
Elizabeth Cruz
Judith E. Nelson
Show All
Source
Cite
Save
Citations (12)
Theranostic trial of well differentiated neuroendocrine tumors (NETs) with somatostatin antagonists 68Ga-OPS202 and 177Lu-OPS201.
2017
Journal of Clinical Oncology
Diane Lauren Reidy
Neeta Pandit-Taskar
Simone Krebs
Joseph A. O’Donoghue
Nitya Prabhakar Raj
Elizabeth Cruz
Hanh Pham
Alicia Lashley
Lisa Bodei
Wolfgang A. Weber
Show All
Source
Cite
Save
Citations (7)
1